Interpace Diagnostics Presents New Data from Over 3,400 Patients Tested with ThyGenX®/ThyraMIR® Oct 18, 2017
Interpace Diagnostics to Present at the Dawson James Securities 3rd Annual Small Cap Growth Stock Conference Oct 17, 2017
Interpace Diagnostics Announces Expansion into New Clinical Area with Launch of Molecular Lung Cancer Test Sep 25, 2017
Interpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Audit Committee Requirements Sep 20, 2017
Interpace Diagnostics Announces New CPT Code for Reimbursement of Molecular Thyroid Test Sep 11, 2017
Interpace Diagnostics Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City Sep 7, 2017
Interpace Diagnostics to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017 Aug 31, 2017
